Bio-Rad Laboratories (BIO) Misses Q4 Earnings and Revenue Estimates
Portfolio Pulse from
Bio-Rad Laboratories (BIO) reported Q4 earnings of $2.90 per share, missing the Zacks Consensus Estimate of $2.93. This is a decrease from $3.10 per share a year ago.
February 14, 2025 | 12:00 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bio-Rad Laboratories reported Q4 earnings of $2.90 per share, missing the consensus estimate of $2.93 and down from $3.10 a year ago.
The earnings miss and year-over-year decline in EPS are likely to negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100